… adenoviral vector systems. These successes and the urgency of the COVID-19 situation
have resulted in a flurry of candidate adenoviral vector … This review details adenoviral vector …

… SARS-CoV-2 encapsulated in lipid nanoparticles and two adenoviral vector-based vaccines,
ie, ChAdOx1 nCoV… chimpanzee adenoviral vector encoding the spike protein of SARS-CoV-…

… events of adenovirus vector or of SARS-CoV-2 RNA reverse transcript DNA at low
frequency versus hopefully high vaccine efficacy and protection. Moreover, since SARS-CoV-2 …

… replication-defective human type 5 adenovirus encoding the SARS-CoV-2 spike protein (Ad5-nCoV)
protect mice completely against mouse-adapted SARS-CoV-2 infection in the upper …

… mRNA-based and an adenoviral vector-based vaccine against … acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) … (Pfizer and Moderna) and adenoviral vector-based (Johnson & …

Patients on maintenance dialysis may be immunocompromised and have comorbidities that
modulate the response to coronavirus disease 2019 (COVID-19) vaccines. We conducted a …

… facility for intranasal instillation of non-replicating adenoviral (Ad) vectors before being
transferred to a BSL-3 facility at ISMMS for challenge with SARS-CoV-2. Mice were housed under …

… ChAdOx1 nCoV-19 (AZD1222, Vaxzevria) is an efficacious vaccine against SARS-CoV-2,
based upon an adenovirus vector. We describe the development of a process for the …

… -2 spike protein was detected only in the ChAdOx1 nCoV-19 vaccine. There may be several
… of the SARS-CoV-2 transgene during the production of the recombinant adenoviral vectors. …

The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible
decreases in vaccine effectiveness. Here, neutralizing antibody titers elicited by mRNA-…